VVOS News and Press, Vivos Therapeutics Inc. From 06/15/23

--News Direct-- Vivos Therapeutics chairman and CEO Kirk Huntsman joins Natalie Stoberman from the Proactive studios to discuss the company's first-quarter financial and operational highlights. Huntsman says the main highlight of comes from acquisition of certain US and international ...

2023-06-09 12:24:03 ET Vivos Therapeutics, Inc. (VVOS) Q1 2023 Earnings Conference Call June 8, 2023, 05:00 PM ET Company Participants Julie Gannon - IR Kirk Huntsman - Chairman & CEO Brad Amman - CFO Conference Call Participants Scott Henry - ROT...

Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing-related sleep issues arising from certain ...

2023-06-08 16:22:53 ET Vivos Therapeutics press release ( NASDAQ: VVOS ): Q1 GAAP EPS of -$0.07 beats by $0.10 . Revenue of $3.86M (+6.0% Y/Y) misses by $0.15M . Shares -3.55% . For further details see: Vivos Therapeutics GAAP EPS of -$0.07 beats ...

Revenue increased 6% Year-Over-Year; Operating Expenses Decreased 20% as Cost Cutting Initiatives Take Hold Management to Host Conference Call Today at 5:00 pm ET LITTLETON, Colo., June 08, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc . (“Vivos” o...

Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing-related sleep issues arising from certain ...

LITTLETON, Colo., June 06, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variet...

Vivos Therapeutics (NASDAQ: VVOS) chairman and CEO Kirk Huntsman recently joined Natalie Stoberman from the Proactive Studio to discuss how the company’s POD device performed a highly effective rate in treating migraine headaches in a clinical study. During the interview, Huntsman said th...

--News Direct-- Vivos Therapeutics chairman and CEO Kirk Huntsman joins Natalie Stoberman from the Proactive studio to discuss how the company's POD device performed a highly effective rate in treating migraine headaches in a clinical study. Huntsman says the study showed 92% of patie...

Vivos Therapeutics (NASDAQ: VVOS) today announced it has implemented a broad set of initiatives aimed at improving operational efficiencies, reducing expenses and positioning Vivos to take advantage of current growth opportunities. According to the update, the initiatives touch most aspects of V...